Microbiomepost discussed with Lisa Derosa, oncologist at Gustave Roussy Hospital in Paris, about the link between gut dysbiosis and cancer, shedding light on its role in immunotherapy resistance and patient survival.
MicrobiomeHUB is a space that brings together the companies of the microbiome industry. Why is that?
Every day, technology shows us that it is possible to be close to each other from miles away. Why not make it a mean for business?
Begin to play your role in the microbiome revolution!
Discover characteristics, functionalities and scientific support of commercial probiotics, including medical informations for each strain.
New therapeutic strategies that rely on TLR4 inhibition can counteract the formation of coronary clots in people with cardiovascular disease.
A new study published in Science claims that some gut microbes produce a metabolite that boosts the effect of a class of cancer drugs.
A new study helps to explain how nerve cells sense the microbes in the gut and how they coordinate their function with other tissues in the digestive tract.
Researchers at UCC Ireland reviewed current knowledge on the microbiota-gut-brain relationship. Their work is published in Cell Metabolism.
There may be more genes in the gut and oral microbiome than previously thought, a large study of the human microbiome claims.
Scientists at KU Leuven summarized existing data on how SCFAs regulate the gut–brain axis, including the impact on the immune, endocrine and neural systems.
Imbalances of microbes, which are normally present on the skin, are one of the main subjects raised during the 24thCongress of Dermatology.
Scientists have traced how the interplay of different species of Staphylococcus bacteria on the skin could influence the severity of skin eczema.
A commensal Lactobacillus strain worsens the symptoms of systemic lupus erythematosus and triggers the host’s immune system.
The gut microbiota reduces the production of retinoic acid, a metabolite of vitamin A, to regulate immune activity and prevent pathogens.
MicrobiomePost.com provides qualified scientific updates to healthcare professionals and to anyone who wants to know more about the microbiome
Published by Clorofilla Srl
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED
